NCT03740529 2026-01-27A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLEli Lilly and CompanyPhase 1/2 Completed803 enrolled 2 FDA
NCT03064867 2022-11-16Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell LymphomaCase Comprehensive Cancer CenterPhase 1/2 Active not recruiting65 enrolled
NCT01415765 2019-12-17MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell LymphomaNational Institutes of Health Clinical Center (CC)Phase 1/2 Withdrawn